Add to ORKGOBJECTIVES: To test whether the addition of melatonin to bright-light therapy enhances the efficacy in treating rest– activity (circadian) disruption in institutionalized patients with Alzheimer’s disease (AD)
Sleep-wake rhythm disturbances in patients with Alzheimer's disease (AD) make a strong demand on car...
Abstract: Neurodegenerative diseases like Alzheimer’s disease (AD) and Parkinson’s disease (PD) are ...
Abstract: Treatment of circadian rhythm disorders, whether precipitated by intrinsic factors (e.g., ...
OBJECTIVES: To test whether the addition of melatonin to bright-light therapy enhances the efficacy ...
CONTEXT: Cognitive decline, mood, behavioral and sleep disturbances, and limitations of activities o...
Context: Cognitive decline, mood, behavioral and sleep disturbances, and limitations of activities o...
It is shown that the circadian system is affected in patients with Alzheimer's disease (AD) even at ...
Abstract: Alzheimer’s disease (AD) is a major health problem and a growing recognition exists that e...
Alzheimer’s disease (AD) is a major health problem and a growing recognition exists that efforts to ...
Abstract: Melatonin secretion decreases in Alzheimer´s disease (AD) and this decrease has been postu...
Alzheimer’s disease (AD) patients exhibit random patterns of rest and activity rather than the conso...
In this thesis circadian rhythm alterations in Alzheimer’s disease (AD) are taken into account, in p...
Alzheimer’s disease (AD) is a neurodegenerative disease without a known cure to date. The number of ...
Mariana G Figueiro,1 Barbara A Plitnick,1 Anna Lok,1 Geoffrey E Jones,1 Patricia Higgins,2,3 Thomas ...
Alzheimer's disease (AD) is a neurodegenerative disease often accompanied with disrup-tion of s...
Sleep-wake rhythm disturbances in patients with Alzheimer's disease (AD) make a strong demand on car...
Abstract: Neurodegenerative diseases like Alzheimer’s disease (AD) and Parkinson’s disease (PD) are ...
Abstract: Treatment of circadian rhythm disorders, whether precipitated by intrinsic factors (e.g., ...
OBJECTIVES: To test whether the addition of melatonin to bright-light therapy enhances the efficacy ...
CONTEXT: Cognitive decline, mood, behavioral and sleep disturbances, and limitations of activities o...
Context: Cognitive decline, mood, behavioral and sleep disturbances, and limitations of activities o...
It is shown that the circadian system is affected in patients with Alzheimer's disease (AD) even at ...
Abstract: Alzheimer’s disease (AD) is a major health problem and a growing recognition exists that e...
Alzheimer’s disease (AD) is a major health problem and a growing recognition exists that efforts to ...
Abstract: Melatonin secretion decreases in Alzheimer´s disease (AD) and this decrease has been postu...
Alzheimer’s disease (AD) patients exhibit random patterns of rest and activity rather than the conso...
In this thesis circadian rhythm alterations in Alzheimer’s disease (AD) are taken into account, in p...
Alzheimer’s disease (AD) is a neurodegenerative disease without a known cure to date. The number of ...
Mariana G Figueiro,1 Barbara A Plitnick,1 Anna Lok,1 Geoffrey E Jones,1 Patricia Higgins,2,3 Thomas ...
Alzheimer's disease (AD) is a neurodegenerative disease often accompanied with disrup-tion of s...
Sleep-wake rhythm disturbances in patients with Alzheimer's disease (AD) make a strong demand on car...
Abstract: Neurodegenerative diseases like Alzheimer’s disease (AD) and Parkinson’s disease (PD) are ...
Abstract: Treatment of circadian rhythm disorders, whether precipitated by intrinsic factors (e.g., ...